{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:07:55Z","timestamp":1788804475544,"version":"build-2803163510"},"reference-count":21,"publisher":"BMJ","funder":[{"name":"Arsenal Medical, Inc.","award":["Not applicable"],"award-info":[{"award-number":["Not applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2026,7,24]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      NeoCast\n                      <jats:sup>TM<\/jats:sup>\n                      is a solvent-free, non-adhesive biomaterial engineered to achieve microvascular occlusion. EMBO-01 is the first-in-human trial of NeoCast for the pre-surgical embolization of hypervascular brain tumors supplied by the middle meningeal artery (MMA).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>EMBO-01 was an open-label, multicenter, prospective, externally monitored, and core lab adjudicated clinical trial. The primary safety endpoint was freedom from device-related disabling stroke or neurological death within 30 days of embolization. The primary effectiveness endpoint was successful injection of NeoCast into targeted vessel(s), resulting in complete occlusion at or distal to the point of embolysate injection. Additional assessments included occurrence of microcatheter adhesion and non-target embolization, percent tumor devascularization, extent of resection, estimated intraoperative blood loss, and surgical time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Five subjects were enrolled with an average tumor size of 5.0\u00b11.2\u2009cm. NeoCast achieved occlusion in all targeted vessels for all subjects. There were no adverse events or device deficiencies during embolization. The average NeoCast injection volume was 0.68\u00b10.28\u2009mL with an average injection time of 7.8\u00b16.4\u2009min. There was no microcatheter entrapment or non-target embolization. The average percent tumor devascularization was 89\u00b17%. Tumor resection was complete in all subjects, with an average estimated blood loss of 240\u00b1164\u2009mL and average total surgery time of 167\u00b175\u2009min. All subjects successfully met both the primary feasibility and safety endpoints.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This first-in-human study provides evidence that NeoCast can be used to reproducibly and safely achieve substantial preoperative devascularization of brain tumors supplied by the MMA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnis-2026-025708","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:20:23Z","timestamp":1786123223000},"page":"jnis-2026-025708","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["A first-in-human, prospective feasibility trial of a next-generation, shear-responsive, liquid embolic biomaterial, NeoCast"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1140-8664","authenticated-orcid":false,"given":"Lee-Anne","family":"Slater","sequence":"first","affiliation":[{"name":"Monash Medical Centre, Clayton, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"de Villiers","sequence":"additional","affiliation":[{"name":"Gold Coast Hospital, Southport, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1536-1613","authenticated-orcid":false,"given":"Adam S","family":"Arthur","sequence":"additional","affiliation":[{"name":"Semmes-Murphey Clinic, Memphis, Tennessee, USA"},{"name":"Department of Neurosurgery, University of Tennessee Health Science Center, Memphis, Tennessee, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Jeffrey","family":"Groom","sequence":"additional","affiliation":[{"name":"Arsenal Medical, Inc, Waltham, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0263-0634","authenticated-orcid":false,"given":"Quynh P","family":"Pham","sequence":"additional","affiliation":[{"name":"Arsenal Medical, Inc, Waltham, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Pekar","sequence":"additional","affiliation":[{"name":"Arsenal Medical, Inc, Waltham, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2677-8780","authenticated-orcid":false,"given":"David","family":"Fiorella","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Stony Brook Medicine, Stony Brook, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2026090710202319000_jnis-2026-025708v2.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2019.02.223"},{"key":"2026090710202319000_jnis-2026-025708v2.2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2214\/AJR.14.12480","article-title":"A case-based approach to common embolization agents used in vascular interventional radiology","volume":"203","author":"Medsinge","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"2026090710202319000_jnis-2026-025708v2.3","doi-asserted-by":"crossref","unstructured":"Ko G , Choi JW , Lee N , et al . Recent progress in liquid embolic agents. Biomaterials 2022;287. doi:10.1016\/j.biomaterials.2022.121634","DOI":"10.1016\/j.biomaterials.2022.121634"},{"key":"2026090710202319000_jnis-2026-025708v2.4","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202404011","article-title":"An in situ curing, shear-responsive biomaterial designed for durable embolization of microvasculature","volume":"14","author":"Pham","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"2026090710202319000_jnis-2026-025708v2.5","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016798"},{"key":"2026090710202319000_jnis-2026-025708v2.6","doi-asserted-by":"publisher","DOI":"10.1007\/s00062-021-01066-6"},{"key":"2026090710202319000_jnis-2026-025708v2.7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1284462"},{"key":"2026090710202319000_jnis-2026-025708v2.8","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-014-0328-7"},{"key":"2026090710202319000_jnis-2026-025708v2.9","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1016\/j.wneu.2019.12.104","article-title":"Postembolization change in magnetic resonance imaging contrast enhancement of meningiomas is a better predictor of intraoperative blood loss than angiography","volume":"135","author":"Catapano","year":"2020","journal-title":"World Neurosurg"},{"key":"2026090710202319000_jnis-2026-025708v2.10","first-page":"255","article-title":"Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas","volume":"21","author":"Bendszus","year":"2000","journal-title":"AJNR Am J Neuroradiol"},{"key":"2026090710202319000_jnis-2026-025708v2.11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/jon.12256","article-title":"MRI pre- and post-embolization enhancement patterns predict surgical outcomes in intracranial meningiomas","volume":"26","author":"Ali","year":"2016","journal-title":"J Neuroimaging"},{"key":"2026090710202319000_jnis-2026-025708v2.12","doi-asserted-by":"publisher","DOI":"10.3171\/2020.6.jns20374"},{"key":"2026090710202319000_jnis-2026-025708v2.13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3171\/2015.9.JNS15754","article-title":"The Simpson grading revisited: aggressive surgery and its place in modern meningioma management","volume":"125","author":"Gousias","year":"2016","journal-title":"J Neurosurg"},{"key":"2026090710202319000_jnis-2026-025708v2.14","doi-asserted-by":"publisher","DOI":"10.3171\/2016.1.JNS151842"},{"key":"2026090710202319000_jnis-2026-025708v2.15","doi-asserted-by":"crossref","unstructured":"Odland IC , Huo L , Feng R , et al . Standalone meningioma embolization: a systematic review. Neurosurgery 2026.:10. doi:10.1227\/neu.0000000000003933","DOI":"10.1227\/neu.0000000000003933"},{"key":"2026090710202319000_jnis-2026-025708v2.16","doi-asserted-by":"crossref","unstructured":"Brake A , Fry L , Young C , et al . E-200\u2005definitive embolization of meningiomas: a 20 year updated review of the literature. SNIS 22nd Annual Meeting Abstracts; July 2025:A228\u20139. doi:10.1136\/jnis-2025-SNIS.315","DOI":"10.1136\/jnis-2025-SNIS.315"},{"key":"2026090710202319000_jnis-2026-025708v2.17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1626753","article-title":"Multicenter evaluation of preoperative and standalone embolization in meningiomas","volume":"15","author":"Yu","year":"2025","journal-title":"Front Oncol"},{"key":"2026090710202319000_jnis-2026-025708v2.18","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1016\/j.wneu.2017.12.003","article-title":"Preoperative embolization of meningiomas: differences in surgical operability and histopathologic changes between Embosphere and N-butyl 2-cyanoacrylate","volume":"111","author":"Arai","year":"2018","journal-title":"World Neurosurg"},{"key":"2026090710202319000_jnis-2026-025708v2.19","first-page":"S91","article-title":"Pre-operative embolization of intracranial and extracranial tumors: a review of 37 cases","volume":"99 Suppl 3","author":"Iampreechakul","year":"2016","journal-title":"J Med Assoc Thai"},{"key":"2026090710202319000_jnis-2026-025708v2.20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.7461\/jcen.2016.18.1.12","article-title":"Preoperative embolization of extra-axial hypervascular tumors with Onyx","volume":"18","author":"Fusco","year":"2016","journal-title":"J Cerebrovasc Endovasc Neurosurg"},{"key":"2026090710202319000_jnis-2026-025708v2.21","first-page":"245","article-title":"Preoperative embolization for parasagittal and convexity meningiomas: efficacy and safety","volume":"34","author":"Wu","year":"2009","journal-title":"Chin J Radiol"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2026-025708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:20:28Z","timestamp":1788801628000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2026-025708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":21,"alternative-id":["10.1136\/jnis-2026-025708"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2026-025708","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]}}}